Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pure Cycle | PCYO | Jan 17, 2025 | 11.55 | -0.35 |
Pure Storage A | PSTG | Jan 17, 2025 | 66.30 | +1.35 |
PureCycle Technologies | PCT | Jan 17, 2025 | 9.58 | +1.81 |
PureCycle Technologies Unit | PCTTU | Jan 17, 2025 | 12.00 | 0.00 |
Purefunds ISE Junior Silver [Sm | SILJ | Jan 17, 2025 | 10.57 | +0.28 |
PureTech Health ADR | PRTC | Jan 17, 2025 | 17.50 | -3.26 |
Purple Biotech ADR | PPBT | Jan 17, 2025 | 3.54 | -4.84 |
Purple Innovation | PRPL | Jan 17, 2025 | 0.95 | -0.16 |
Pursuit Attractions & Hospitality | PRSU | Jan 17, 2025 | 39.89 | 0.00 |
Putnam Managed Municipal Income Trust | PMM | Jan 17, 2025 | 6.13 | 0.00 |
Putnam Master Intermediate Income Trust | PIM | Jan 17, 2025 | 3.28 | 0.00 |
Putnam Municipal Opportunities Trust | PMO | Jan 17, 2025 | 10.29 | -0.10 |
Putnam Premier Income Trust | PPT | Jan 17, 2025 | 3.55 | -0.28 |
PVH | PVH | Jan 17, 2025 | 92.78 | +0.63 |
Pyrophyte Acquisition | PHYT | Jan 17, 2025 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | Jan 17, 2025 | 1.50 | +2.04 |
Pyxis Tankers | PXS | Jan 17, 2025 | 3.94 | +0.77 |
Q2 | QTWO | Jan 17, 2025 | 93.91 | +0.59 |
Q32 Bio | QTTB | Jan 17, 2025 | 3.28 | +4.46 |
QCR | QCRH | Jan 17, 2025 | 80.70 | +0.11 |
QIAGEN | QGEN | Jan 17, 2025 | 46.00 | +0.22 |
Qifu Technology ADR | QFIN | Jan 17, 2025 | 38.37 | +3.59 |
QMMM | QMMM | Jan 17, 2025 | 0.84 | +3.05 |
Qorvo | QRVO | Jan 17, 2025 | 84.21 | +14.43 |
QT Imaging | QTI | Jan 17, 2025 | 0.47 | -11.02 |
Quad Graphics A | QUAD | Jan 17, 2025 | 6.76 | +1.20 |
Quaker Houghton | KWR | Jan 17, 2025 | 136.37 | +2.62 |
QUALCOMM | QCOM | Jan 17, 2025 | 164.56 | +1.94 |
Qualigen Therapeutics | QLGN | Jan 17, 2025 | 4.07 | +1.75 |
Qualys | QLYS | Jan 17, 2025 | 136.97 | +0.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.